Multiple Assemblies exist for SMTL entry 5n2k
Structure of unbound Briakinumab FAb; X-RAY DIFFRACTION 2.22 Å

	SMTL ID 5n2k.1 Ligands - Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.2 Ligands - Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.3 Ligands - Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.4 Ligands - Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.5 Ligands 1,2-ETHANEDIOL Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.6 Ligands - Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.7 Ligands - Polypeptides Briakinumab FAb light chain; Briakinumab FAb heavy chain Oligo-state hetero-1-1-mer
	SMTL ID 5n2k.8 Ligands - Polypeptides Briakinumab FAb heavy chain; Briakinumab FAb light chain Oligo-state hetero-1-1-mer